These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Sodi R; Fikri R; Diver M; Ranganath L; Vora J Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128 [TBL] [Abstract][Full Text] [Related]
7. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. Gillam MP; Middler S; Freed DJ; Molitch ME J Clin Endocrinol Metab; 2002 Oct; 87(10):4447-51. PubMed ID: 12364416 [TBL] [Abstract][Full Text] [Related]
8. In vivo effects of progestins on prolactin secretion. Sitruk-Ware R; Varin C; Clair F; Maugis E; Fermanian J; Mauvais-Jarvis P J Clin Endocrinol Metab; 1985 Mar; 60(3):575-8. PubMed ID: 3919048 [TBL] [Abstract][Full Text] [Related]
9. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced prolactinoma in a man. Gooren LJ; Assies J; Asscheman H; de Slegte R; van Kessel H J Clin Endocrinol Metab; 1988 Feb; 66(2):444-6. PubMed ID: 3339116 [TBL] [Abstract][Full Text] [Related]
11. Return of gonadal function in men with prolactin-secreting pituitary tumors. Murray FT; Cameron DF; Ketchum C J Clin Endocrinol Metab; 1984 Jul; 59(1):79-85. PubMed ID: 6427273 [TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinaemia in males with and without pituitary macroadenomas. Spark RF; Wills CA; O'Reilly G; Ransil BJ; Bergland R Lancet; 1982 Jul; 2(8290):129-32. PubMed ID: 6123841 [TBL] [Abstract][Full Text] [Related]
13. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. Colao A; Vitale G; Cappabianca P; Briganti F; Ciccarelli A; De Rosa M; Zarrilli S; Lombardi G J Clin Endocrinol Metab; 2004 Apr; 89(4):1704-11. PubMed ID: 15070934 [TBL] [Abstract][Full Text] [Related]
14. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma. Dalzell GW; Atkinson AB; Carson DJ; Sheridan B Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115 [TBL] [Abstract][Full Text] [Related]
15. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. Colao A; Di Sarno A; Sarnacchiaro F; Ferone D; Di Renzo G; Merola B; Annunziato L; Lombardi G J Clin Endocrinol Metab; 1997 Mar; 82(3):876-83. PubMed ID: 9062500 [TBL] [Abstract][Full Text] [Related]
16. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine]. Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068 [TBL] [Abstract][Full Text] [Related]
17. [Bromocriptine therapy of prolactinoma in pregnancy]. Nehmzow M; Ventz M; Meng W Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805 [TBL] [Abstract][Full Text] [Related]